Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2014
12/10/2014CN103073620B Kdr肽和包括该肽的疫苗 Kdr peptides and vaccines comprising the peptide
12/10/2014CN103055295B 一种治疗腰椎间盘突出及骨质增生的中药和其使用方法 A lumbar intervertebral disc and bone hyperplasia treatment of traditional Chinese medicine and its use
12/10/2014CN103044377B 具有抑制黄嘌呤氧化酶和降尿酸作用的化合物以及组合物 Has the compounds and compositions inhibit xanthine oxidase and uric acid lowering effects
12/10/2014CN102822170B 作为cFMS抑制剂的取代的N-(1H-吲唑-4-基)咪唑并[1,2-a]吡啶-3-羧酰胺化合物 As cFMS inhibitors substituted N- (1H- indazol-4-yl) imidazo [1,2-a] pyridine-3-carboxamide compound
12/10/2014CN102321626B 用于抑制蛋白激酶3表达的方法 Method for inhibiting the expression of protein kinase 3
12/10/2014CN102015718B 作为糖原合酶激酶3抑制剂的1-(7-(六氢吡咯并[3，4-c]-吡咯-2(1h)-基)喹啉-4-基)-3-(吡嗪-2-基)脲衍生物和相关的化合物 As glycogen synthase kinase 3 inhibitors of 1- (7- (hexahydro-pyrrolo [3,4-c] - pyrrole -2 (1h) - yl) quinolin-4-yl) -3- (pyrazine 2-yl) urea derivatives and related compounds
12/10/2014CN101721702B 用于治疗TNF-α相关疾病的人抗体的制剂 For the treatment of TNF-α-related diseases of a human antibody preparation
12/10/2014CN101370394B 山药低分子提取物与制备方法 Yam extract and preparation of low molecular weight
12/09/2014US8906966 Medicaments containing panthenol
12/09/2014US8906953 Pyrrolidine substitute flavones for the treatment of inflammatory disorders
12/09/2014US8906675 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
12/04/2014US20140357586 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
12/04/2014US20140356327 Gene therapy for spinal cord disorders
12/02/2014US8901313 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/02/2014US8901280 Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
12/02/2014US8901118 Compounds and methods for kinase modulation, and indications therefor
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8900640 Expandable, porous apatite/collagen composite, and its production method
11/2014
11/27/2014US20140348879 Enteric soft capsules
11/27/2014US20140348849 Compounds and Method for Modulating Inflammatory Reactions
11/25/2014US8895253 Integrin heterodimer and a subunit thereof
11/20/2014US20140343025 Pharmaceutical composition
11/20/2014US20140342930 Methods for selective targeting
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/18/2014US8889658 Phosphonate compounds
11/18/2014US8889652 Pharmaceutical agent having long-lasting effect of treating arthritic disorders
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/13/2014US20140335549 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
11/13/2014US20140335209 Pawpaw and/or peach derived composition
11/11/2014US8883862 Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel
11/11/2014US8883856 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
11/11/2014US8883849 Treatment of sleep disturbances
11/11/2014US8883504 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line
11/11/2014US8883473 Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases
11/11/2014US8883425 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/04/2014US8877927 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors
11/04/2014US8877712 Use of Del-1 in hair, bone and cartilage regeneration
11/04/2014US8877242 Sustained-release drug carrier composition
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871786 Azaindazole amide compounds as CCR1 receptor antagonists
10/28/2014US8871775 Compounds
10/28/2014US8871226 Methods and compositions for the treatment and diagnosis of cancer
10/21/2014US8865689 Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
10/14/2014US8859855 Chimeric PUFA polyketide synthase systems and uses thereof
10/14/2014US8859729 Growth hormone releasing peptides
10/14/2014US8859612 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation
10/14/2014US8859545 Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases
10/14/2014US8859008 Bone substitute and method for the preparation thereof
10/09/2014WO2014165136A1 Constant volume prefilled syringes and kits thereof
10/09/2014WO2014163568A1 Probiotic strains for use in treatment or prevention of osteoporosis
10/09/2014WO2014163030A1 Preparation for treating equine inflammation
10/09/2014WO2014161872A1 Compositions for use in stimulating bone growth
10/09/2014WO2014161570A1 Antibodies against human il17 and uses thereof
10/09/2014WO2014161075A1 Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140303077 Albumin fusion proteins
10/08/2014EP2786782A1 Sulphated hyaluronic acid for treating degenerative osteoarthritis
10/08/2014EP2785359A1 Mesenchymal stromal cells and uses related thereto
10/07/2014US8853361 Preparation, for use, in particular, for tissue augmentation and healing
10/07/2014US8853200 Treatment of rheumatoid arthritis with 3-amino lactam compounds
10/07/2014US8853187 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
10/07/2014US8853165 Peptide having the ability to regenerate bone tissue and for binding to apatite
10/07/2014US8853160 GLP-1, exendin-4, peptide analogs and uses thereof
10/07/2014US8852551 Methods to impair hematologic cancer progenitor cells and compounds related thereto
10/02/2014WO2014159863A1 Thermo-sensitive bone growth compositions
10/02/2014WO2014159725A1 Proteins specific for baff and b7rp1 and uses thereof
10/02/2014WO2014158033A1 Stabilized vitamin d formulations
10/02/2014WO2014157811A1 Composition for remedying or treating rheumatoid arthritis and osteoarthritis
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157569A1 Heterocyclic compound
10/02/2014WO2014157436A1 Pharmaceutical composition for external application
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157229A1 Tace peptide epitope, antihuman tace protein antibody and hybridoma producing antibody
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014WO2014154727A1 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014WO2014154726A1 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014WO2014153627A1 Tendon healing composition and formulation, and uses thereof
10/02/2014WO2014153614A1 Improved methods for osteoarthritis therapy
10/02/2014US20140294829 Anti-ngf antibodies for the treatment of various disorders
10/01/2014EP2784090A1 Compositions for the treatment of systemic onset juvenile idiopathic arthritis
10/01/2014EP2783687A1 Composition for inhibition of cathepsin K
09/2014
09/30/2014US8846910 Matrix metalloproteinase inhibitors
09/25/2014WO2014153435A1 Methods for treating osteogenesis imperfecta
09/25/2014WO2014152621A1 P2x7 modulators
09/25/2014WO2014152537A1 P2x7 modulators
09/25/2014WO2014152114A1 Heteroaromatic compounds as btk inhibitors
09/25/2014WO2014151923A1 Factor h for treatment of rheumatoid arthritis
09/25/2014WO2014151620A1 5-thiazolecarboxamide dervatives and their use as btk inhibitors
09/25/2014WO2014151180A1 Treatment of psoriatic arthritis using apremilast
09/25/2014WO2014150687A1 Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring
09/25/2014WO2014149789A1 Combination of canagliflozin and probenecid for the treament of hyperuricemia
09/25/2014WO2014149270A1 Treatment of pain using protein solutions
09/25/2014WO2014148718A1 Bone morphogenetic compound and application thereof
09/25/2014WO2014148592A1 Method for preparing chondrocytes
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014148489A1 Cyclic peptide
09/25/2014WO2014148053A1 Use of ep4 receptor antagonists in the treatment of cartilage disease
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 820